VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

NCT00116844 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Herpesviridae

Interventions

DRUG: Valaciclovir
DRUG: Placebo

Sponsor

GlaxoSmithKline